drugset / Trial / NCT02108496

Verifying the Effectiveness of the NUsurface® System

NCT02108496

Completed 127 enrolled Active Implants
RandomizedParallel-groupOpen-labelTreatment

Summary

The NUsurface® Meniscus Implant Randomized Study is a multi-center, prospective randomized, interventional clinical trial to test the hypothesis that the NUsurface implant is superior to the non-surgical standard of care in treating the target population.The rationale for performing this clinical study is to gather clinical data to evaluate the safety and effectiveness of the NUsurface device compared to the Standard of Care.

Timeline

Start
2014-07
Primary completion
2021-06
Completion
2022-05-03

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hylan G-F 20 Other / unclassified Other
Comparator Triamcinolone Other / unclassified 40 mg Other

Indications